Search results
Results From The WOW.Com Content Network
Armodafinil exhibits linear time-independent kinetics following single and multiple oral dose administration. Increase in systemic exposure is proportional over the dose range of 50–400 mg. No time-dependent change in kinetics was observed through 12 weeks of dosing. Apparent steady state for armodafinil was reached within 7 days of dosing.
The tenth edition, published in 2010 and edited by Cynthia M. Kahn, was the first to contain images. [2] It included radiographs, illustrations, and photomicrographs, as well as new chapters, including one on African hedgehogs. [2] The eleventh edition, published in 2016, had over 400 contributing authors. [10]
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant and eugeroic (wakefulness promoter) medication used primarily to treat narcolepsy, [3] [8] [15] a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks. [16]
[3] [2] [4] The modafinil analogues are of interest in the potential treatment of a condition involving the misuse of stimulant drugs (psychostimulant use disorder or PSUD), as drugs that help increase motivation (pro-motivational agents) to treat motivational disorders, [4] [5] [6] and for treatment of neurodegenerative diseases such as ...
Dog Owners' Ideas and Strategies Regarding Dental Health in Their Dogs-Thematic Analysis of Free Text Survey Responses. Front Vet Sci. 2022 May 3;9:878162. doi: 10.3389/fvets.2022.878162. PMID ...
1. Ketogenic Diet. Cancer cells rely on glucose for energy to grow. The ketogenic diet is a way to provide an alternative energy source to normal cells in the dog's body while starving the cancer ...
Martindale: The Complete Drug Reference is a reference book published by Pharmaceutical Press listing some 6,000 drugs and medicines used throughout the world, including details of over 125,000 proprietary preparations. It also includes almost 700 disease treatment reviews.
From January 2008 to December 2012, if you bought shares in companies when Robert D. Walter joined the board, and sold them when he left, you would have a 10.3 percent return on your investment, compared to a -2.8 percent return from the S&P 500.